PEN vs RMD · P/E 237, rev $764.8M vs P/E 29, rev $5.65B
Penumbra Inc (PEN) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Penumbra Inc (PEN) is a medical devices company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported PEN revenue for 2026-06-30 was $764.8M. Net income was $67.4M. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
PEN currently screens at market cap $9.93B and trailing P/E 237.4. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the PEN and RMD stock pages for the full models.
Not investment advice.